What is the official website of Sandoz India Pvt Ltd ?

The official website of Sandoz India Pvt Ltd is http://www.sandoz.com.

What is Sandoz India Pvt Ltd's cybersecurity risk score?

Sandoz India Pvt Ltd has an AI-generated cybersecurity risk score of 758 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz India Pvt Ltd experienced?

According to Rankiteo, Sandoz India Pvt Ltd currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz India Pvt Ltd been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz India Pvt Ltd has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz India Pvt Ltd have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz India Pvt Ltd is not certified under SOC 2 Type 1.

Does Sandoz India Pvt Ltd have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz India Pvt Ltd does not hold a SOC 2 Type 2 certification.

Does Sandoz India Pvt Ltd comply with GDPR ?

According to Rankiteo, Sandoz India Pvt Ltd is not listed as GDPR compliant.

Does Sandoz India Pvt Ltd have PCI DSS certification ?

According to Rankiteo, Sandoz India Pvt Ltd does not currently maintain PCI DSS compliance.

Does Sandoz India Pvt Ltd comply with HIPAA ?

According to Rankiteo, Sandoz India Pvt Ltd is not compliant with HIPAA regulations.

Does Sandoz India Pvt Ltd have ISO 27001 certification ?

According to Rankiteo,Sandoz India Pvt Ltd is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz India Pvt Ltd operate in ?

Sandoz India Pvt Ltd operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz India Pvt Ltd have ?

Sandoz India Pvt Ltd employs approximately 973 people worldwide.

Does Sandoz India Pvt Ltd own any subsidiaries ?

Sandoz India Pvt Ltd presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz India Pvt Ltd have ?

Sandoz India Pvt Ltd's official LinkedIn profile has approximately 25,507 followers.

What is the NAICS classification code for Sandoz India Pvt Ltd ?

Sandoz India Pvt Ltd is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz India Pvt Ltd have a Crunchbase profile ?

No, Sandoz India Pvt Ltd does not have a profile on Crunchbase.

Does Sandoz India Pvt Ltd have a LinkedIn profile ?

Yes, Sandoz India Pvt Ltd maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoz-india.

How many cybersecurity incidents has Sandoz India Pvt Ltd experienced ?

As of June 6, 2026, Rankiteo reports that Sandoz India Pvt Ltd has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz India Pvt Ltd have ?

Sandoz India Pvt Ltd has an estimated 5,673 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SIPL

Boost Score +25 with badge (5 left)

758

/1000

Fair

783

/1000

Fair

Sandoz India Pvt Ltd Vendor Cyber Rating & Cyber Score

sandoz.com

Add Your Compliance Badge

Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people's lives.

SIPL A.I CyberSecurity Scoring

Scoring History

SIPL

Sandoz India Pvt Ltd CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

SIPL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SIPL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz India Pvt Ltd in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz India Pvt Ltd in 2026.

Incident Types SIPL vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz India Pvt Ltd in 2026.

Incident History - SIPL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz India Pvt Ltd Subsidiaries

SIPL

Pharmaceutical Manufacturing

Website: http://www.sandoz.com

Company Size: 1,001-5,000 employees

SandozPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Sandoz ItaliaPharmaceutical Manufacturing

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz IberiaPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz RomaniaPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Loading…

Sandoz India Pvt Ltd Similar Companies

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Loading…

NEWS

Sandoz India Pvt Ltd CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 04, 2024 07:00 AM

Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024

The event garnered deep insights into current trends, challenges, and opportunities, engaging over 175 senior delegates, industry leaders, and innovators.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-7654

SUMMARY

The Admin Columns plugin for WordPress is vulnerable to PHP Object Injection leading to Remote Code Execution in versions up to and including 7.0.18. This is due to the use of `unserialize()` without an `allowed_classes` restriction in the `IdsToCollection::get_ids_from_string()` function, which processes attacker-controlled post meta values without proper validation. This makes it possible for authenticated attackers with Contributor-level access and above to inject a serialized PHP object into a post's custom meta field and trigger arbitrary code execution by exploiting a bundled POP gadget chain, resulting in remote code execution as the web server user.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-7523

SUMMARY

The Alba Board plugin for WordPress is vulnerable to authorization bypass in all versions up to, and including, 2.1.3. This is due to the plugin not properly verifying that a user is authorized to perform an action. This makes it possible for authenticated attackers, with subscriber-level access and above, to access arbitrary private alba_card post data, including title, description, assignee, due date, tags, and comments, that is intended to be restricted to Administrators and Editors. The handler is registered via the wp_ajax_nopriv_ hook and its nonce is exposed to all site visitors through wp_localize_script on pages containing the [alba_board] shortcode, making this exploitable by unauthenticated users who can access any such page.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-45409

SUMMARY

Internationalized Domain Names in Applications (IDNA) for Python provides support for Internationalized Domain Names in Applications (IDNA) and Unicode IDNA Compatibility Processing. In versions prior to 3.15, payloads such as `"\u0660" * N` or `"\u30fb" * N + "\u6f22"` utilize the `valid_contexto` function prior to length rejection, and for high values of `N` will take a long time to process. This is the same issue as CVE-2024-3651, however the original remediation in 2024 was not a complete fix. A specially crafted argument to the `idna.encode()` function could consume significant resources. This may lead to a denial-of-service. Starting in version 3.14, the function rejects long inputs as soon as practicable prior to any further processing to minimize resource consumption. In version 3.15, this approach was extended to lesser used alternate functions (i.e. per-label conversions and codec support). A workaround is available. Domain names cannot exceed 253 characters in length. If this length limit is enforced prior to passing the domain to the `idna.encode()` function, it should no longer consume significant resources. This is triggered by arbitrarily large inputs that would not occur in normal usage, but may be passed to the library assuming there is no preliminary input validation by the higher-level application.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/kjd/idna/security/advisories/GHSA-65pc-fj4g-8rjx

CVE-2026-11431

SUMMARY

A path traversal vulnerability exists in the Projects Service download endpoint shared by Altium Enterprise Server and Altium 365. An authenticated user can supply a crafted path parameter that bypasses validation, allowing arbitrary files (including entire directories returned as archives) to be read from the server filesystem. Because the readable files include service configuration and credential material, exploitation can be used to gather information enabling further compromise. The issue can be combined with CVE-2026-11424 to reach the cloud-side endpoint. On multi-tenant Altium 365 deployments, the readable configuration could have exposed credentials shared across services. Altium Enterprise Server is fixed in 8.1.1; the issue has been remediated in Altium 365 at the service level.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: )

cvss4

Base Score: 8.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://www.altium.com/platform/security-compliance/security-advisories

CVE-2026-11429

SUMMARY

A path traversal vulnerability exists in the Git Service component shared by Altium Enterprise Server and Altium 365. The service accepts a sequence of post-clone file-manipulation operations that use user-supplied paths without validation, allowing an authenticated user with basic git access to move arbitrary files outside the intended repository area. This file-move primitive can be used to place attacker-controlled script content into directories where it is later executed by the service, resulting in remote code execution under the Git Service account. On multi-tenant Altium 365 deployments, this could have allowed access to data belonging to other tenants on the same infrastructure node. Altium Enterprise Server is fixed in 8.1.1; the issue has been remediated in Altium 365 at the service level.

Published

Date2026-06-05

Updated

Date2026-06-05

RISK INFORMATION (Score: )

cvss4

Base Score: 9.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://www.altium.com/platform/security-compliance/security-advisories

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…